Generics

Biogen’s Tecfidera is indicated for the treatment of relapsing forms of multiple sclerosis and is the first generic of any MS treatment in an oral solid dosage form.

A Delaware district court has decided that HEC Pharm's generic fingolimod will infringe the dosage regimen patent for Novartis' Gilenya.

The Protonix brand had a market value of approximately $43 million for the last 12 months ending in June 2020, according to IQVIA.

Eugia Pharma's generic Nolvadex provides a treatment for certain types of breast cancer in women and men.

Flovent Diskus had a market value of $94 million for the 12 months ended June 2020, according to IQVIA.

Aurobindo's methocarbamol tablets are available in a dosage strength of 750 mg.

Camber’s generic Effexor is available in dosage strengths of 37.5 mg 75 mg, and 150 mg.

K-Tab and potassium chloride extended-release tablets had a market value of approximately $346 million for the 12 months ended March 2020, according to IQVIA.